Cover Image
市場調查報告書

白蛋白(賦形劑)的全球市場 (各類型(人體血清白蛋白,牛血清白蛋白,基因改造型白蛋白)·各用途) :產業分析,市場規模·佔有率·生產量·成長率·趨勢·未來預測

Albumin (Excipient) Market by Type (Human Serum Albumin, Bovine Serum Albumin and Recombinant Albumin) and by Application - Global Industry Analysis, Size, Share, Volume, Growth, Trends and Forecast 2014 - 2020

出版商 Transparency Market Research 商品編碼 324611
出版日期 內容資訊 英文 87 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
白蛋白(賦形劑)的全球市場 (各類型(人體血清白蛋白,牛血清白蛋白,基因改造型白蛋白)·各用途) :產業分析,市場規模·佔有率·生產量·成長率·趨勢·未來預測 Albumin (Excipient) Market by Type (Human Serum Albumin, Bovine Serum Albumin and Recombinant Albumin) and by Application - Global Industry Analysis, Size, Share, Volume, Growth, Trends and Forecast 2014 - 2020
出版日期: 2015年01月14日 內容資訊: 英文 87 Pages
簡介

在新產品的開發過程中適當地選擇賦形劑是藥物製劑的關鍵之一。適當地選擇賦形劑的標準仰賴於添加物的物理·化學·生物學特性。賦形劑基本上是在製造、輸送、儲存過程中用於安定藥物、防止其分解、酸化、凝結。預配方研究便是要研究藥劑與賦形劑之間的交互作用、選定具有可讓最終產品擁有期望性質的賦形劑。白蛋白是一種全新性質的蛋白質,同時具備有治療藥、診斷藥及賦形劑的功能。作為賦形劑,白蛋白廣泛用於劑形、藥物研發及生產疫苗等領域,是生產疫苗用媒介之構成要素。白蛋白由於其安定性特性,而具有60℃連續10小時加熱便可讓病毒去活性化。

本報告提供全球的白蛋白市場·產業相關分析,提供您技術性特性和產品開發的進展,基本的產業結構·競爭力,成長促進·阻礙因素,各產品·各用途·地區別的市場趨勢預測(過去4年·今後5年份),以及主要企業簡介等調查評估。

第1章 序文

第2章 摘要整理

第3章 白蛋白市場概要

  • 簡介
  • 市場動態
    • 推動因素
      • 白蛋白的需求隨著賦形劑的產品穩定性的改善而擴大
      • 隨著蛋白質純化及分子分離技術的改善而推動了市場的成長
      • 基因改造型白蛋白的使用推動了市場的成長
    • 阻礙因素
      • 由於嚴格的法規及成本,醫療上的問題,預測將對市場產生負面影響
      • 轉換到無血清·特殊·客制化媒介液的動向,可能阻礙白蛋白市場的發展
    • 市場機會
      • 由於白蛋白在奈米技術等用途的擴大,白蛋白市場 (特別是基因改造型白蛋白市場) 有變革的可能性
      • 由於致力於新興國家地區的發展,有開拓白蛋白市場巨大市場機會的可能性
  • 波特的五力分析
  • 市場魅力分析:全球各地的白蛋白市場
  • 近幾年趨勢的影響分析
  • 臨床實驗平台分析

第4章 全球白蛋白的市場收益額:不同種類的明細

  • 簡介
    • 全球白蛋白市場收益額:各類型 (總計9年份)
    • 比較分析:不同種類的收益額 (最新值·預測值、%)
    • 白蛋白的價格分佈:各類型
  • 人體血清白蛋白 (HSA)
  • 牛血清白蛋白 (BSA)
  • 基因改造型白蛋白 (r白蛋白)

第5章 全球白蛋白市場收益額·市場規模:各用途

  • 簡介
    • 市場收益額:各用途 (總計9年份)
    • 比較分析:各用途的收益額 (最新值·預測值、%)
  • 製劑及藥物遞輸
  • 疫苗
    • 全球疫苗市場收益額 (以金額為準,總計9年份)
    • 全球疫苗市場規模 (以數量為準,總計9年份)
  • 媒介的成分

第6章 全球白蛋白市場收益額·市場規模:各地區

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區 (RoW)

第7章 建議

  • 成功的市場策略
  • 應該考慮的障礙

第8章 企業簡介

  • CSL Behring LLC
    • 企業概要
    • 財務概要
    • 產品系列
    • 產業策略
    • 最近的發展趨勢
  • HiMedia Laboratories
  • InVitria(Ventria Bioscience)
  • MedxBio Pte. Ltd.
  • 田邊三菱製藥
  • Novozymes A/S
  • Octapharma AG
  • Ray Biotech Inc.
  • Sigma-Aldrich Corporation
  • Thermo Fisher Scientific

圖表一覽

目錄

Title: Albumin (Excipient) Market (Types: Human Serum Albumin, Bovine Serum Albumin and Recombinant Albumin; Applications: Drug Formulation and Drug Delivery, Vaccines, and Component of Media) - Global Industry Analysis, Size, Share, Volume, Growth, Trends and Forecast 2014 - 2020.

Appropriate selection of excipients during the new product development is one of the critical in the pharmaceutical formulations. Criteria for selection of suitable excipient depend on the physical, chemical and biological properties of the excipient. Primarily, it should help stabilize and protect the drug/active pharmaceutical ingredient (API) in the formulation against degradation, oxidation or aggregation, during manufacturing, transport and storage. Preformulation studies comprise investigation of drug-excipient interactions that help in selection of appropriate excipients to achieve the desired properties for the final drug product. Albumin is a well characterized protein and functions as a therapeutic, diagnostic agent, as well as an excipient. As an excipient, albumin has wide applications in drug formulation, drug delivery, vaccine manufacturing and as a component of media in vaccine production. Stable nature of albumin makes its handling and storage easier than other proteins, making it suitable for use as an excipient. Albumin due to its intrinsic stability can be heated at 60°C for 10 hours facilitating virus inactivation during manufacturing.

This report studies the global market for albumin encompassing type, applications and geography. Types of albumin include human serum albumin, bovine serum albumin and recombinant albumin. Major applications for albumin as an excipient comprise drug formulation and drug delivery, vaccines and component of medium. Each of these segments has been analyzed in detail from market trends and recent developments to future outlook and opportunities. The report provides the albumin market size in terms of value (USD million) and volume (kg) for each segment and sub-segment for the period from 2012 to 2020, considering the macro- and micro environmental factors. In addition, the compounded annual growth rate (CAGR) of the overall albumin market and the segments has also been provided in the report for the forecast period 2014 to 2020, considering 2012 as historical year and 2013 as the base year. The global albumin market report also includes an elaborate executive summary, which covers a market snapshot representing key findings from the study.

Geographically, the global albumin market has been segmented into four regions: North America, Europe, Asia Pacific and Rest of the World (RoW). The market size and forecast in terms of value (USD million) and volume (kg) for each of these regions along with the CAGR for the forecast period from 2014 to 2020 have been provided in the report. A detailed qualitative analysis of the major factors determining market dynamics such as drivers, restraints and opportunities, along with the market attractiveness analysis are discussed in the market overview section of the report. The study also provides a list of recommendations for new companies willing to enter the market and for existing companies to increase market shares, which is likely to help in the decision-making process. Event impact analysis and clinical pipeline analysis have also been provided for albumin as an excipient in this report that will help in understanding the major events impacting the albumin market growth. Number of clinical trials also demonstrates the potential of albumin use as an excipient in pharmaceutical formulations.

The study is a robust combination of primary and secondary research. Primary research formed the bulk of our research efforts with information collected from telephonic interviews and interaction via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases for patents, clinical trials, demographics, disease incidence/prevalence, etc. The key players operating in the albumin market are CSL Behring LLC, HiMedia Laboratories Pvt. Ltd., InVitria, MedzBio Pte. Ltd., Mitsubishi Tanabe Pharma Corporation, Novozymes A/S, Octapharma AG, RayBiotech, Inc., Sigma-Aldrich Corporation, and Thermo Fisher Scientific.

The global albumin market is segmented as follows:

  • Albumin Market Revenue (USD Million), by Type
    • Human Serum Albumin
    • Bovine Serum Albumin
    • Recombinant Albumin
  • Albumin Market Revenue (USD Million) and Volume (kg), by Application
    • Drug Formulation and Drug Delivery
    • Vaccines
    • Component of Medium
  • Albumin Market Revenue (USD Million) and Volume (kg), by Geography
    • North America
    • Europe
    • Asia Pacific
    • Rest of the World

Table of Contents

Chapter 1 - Preface

  • 1.1. Report Description
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Sources
      • 1.3.1.1. Secondary Research
      • 1.3.1.2. Primary Research
    • 1.3.2. Assumptions and Limitations
  • 1.4. List of Abbreviations

Chapter 2 - Executive Summary

  • 2.1. Market Snapshot: Global Albumin Market (2013 & 2020)
  • 2.2. Comparative Analysis: Global Albumin Market Revenue, by Geography, 2013 & 2020 (Value %)
  • 2.3. Global Albumin Market Volume, by Geography, 2012 - 2020 (Kilograms)

Chapter 3 - Albumin Market Overview

  • 3.1. Introduction
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
      • 3.2.1.1. Improved product stability with albumin as an excipient leading to increase in demand
      • 3.2.1.2. Improvements in protein purification and molecular separation technology to boost market growth
      • 3.2.1.3. Use of recombinant albumin to drive the albumin market
    • 3.2.2. Restraints
      • 3.2.2.1. Stringent regulations, cost and health care issues are anticipated to affect the market
      • 3.2.2.2. Trend toward serum-free, specialty and customized media solutions could hamper the albumin market
    • 3.2.3. Opportunities
      • 3.2.3.1. Expanding applications of albumin such as nanotechnology would revolutionize the albumin market, particularly recombinant albumin
      • 3.2.3.2. Focus on emerging regions to provide immense potential for the global albumin market
  • 3.3. Porter's Five Force Analysis for the Global Albumin Market
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Bargaining Power of Buyers
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Threat of New Entrants
    • 3.3.5. Competitive Rivalry
  • 3.4. Market Attractiveness Analysis: Global Albumin Market, by Geography, 2013
  • 3.5. Event Impact Analysis
  • 3.6. Clinical Pipeline Analysis

Chapter 4 - Global Albumin Market Revenue (USD Million), by Type, 2012 - 2020

  • 4.1. Introduction
    • 4.1.1. Global Albumin Market Revenue, by Type, 2012 - 2020 (USD Million)
    • 4.1.2. Comparative Analysis: Global Albumin Market Revenue, by Type, 2013 & 2020 (Value %)
    • 4.1.3. Price Range for Each Albumin Type
  • 4.2. Human Serum Albumin (HSA)
    • 4.2.1. Global HSA Market Revenue, 2012 - 2020 (USD Million)
  • 4.3. Bovine Serum Albumin (BSA)
    • 4.3.1. Global BSA Market Revenue, 2012 - 2020 (USD Million)
  • 4.4. Recombinant Albumin (rAlbumin)
    • 4.4.1. Global rAlbumin Market Revenue, 2012 - 2020 (USD Million)

Chapter 5 - Global Albumin Market Revenue (USD Million) and Volume (kg), by Application, 2012 - 2020

  • 5.1. Introduction
    • 5.1.1. Global Albumin Market Revenue, by Application, 2012 - 2020 (USD Million)
    • 5.1.2. Comparative Analysis: Global Albumin Market Revenue, by Application, 2013 & 2020 (Value %)
  • 5.2. Drug Formulation and Drug Delivery
    • 5.2.1. Global Drug Formulation and Drug Delivery Market Revenue, 2012 - 2020 (USD Million)
    • 5.2.2. Global Drug Formulation and Drug Delivery Market Volume, 2012 - 2020 (kilograms)
  • 5.3. Vaccines
    • 5.3.1. Global Vaccines Market Revenue, 2012 - 2020 (USD Million)
    • 5.3.2. Global Vaccines Market Volume, 2012 - 2020 (kilograms)
  • 5.4. Component of Media
    • 5.4.1. Global Component of Media Market Revenue, 2012 - 2020 (USD Million)
    • 5.4.2. Global Component of Media Market Volume, 2012 - 2020 (kilograms)

Chapter 6 - Global Albumin Market Revenue (USD Million) & Volume (kg), by Geography, 2012 - 2020

  • 6.1. Overview
    • 6.1.1. Global Albumin Market Revenue, by Geography, 2012 - 2020 (USD Million)
    • 6.1.2. Global Albumin Market Volume, by Geography, 2012 - 2020 (kilograms)
  • 6.2. North America
    • 6.2.1. North America Albumin Market Revenue, 2012 - 2020, (USD Million)
    • 6.2.2. North America Albumin Market Volume, 2012 - 2020, (kilograms)
  • 6.3. Europe
    • 6.3.1. Europe Albumin Market Revenue, 2012 - 2020 (USD Million)
    • 6.3.2. Europe Albumin Market Volume, 2012 - 2020 (kilograms)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Albumin Market Revenue, 2012 - 2020 (USD Million)
    • 6.4.2. Asia Pacific Albumin Market Volume, 2012 - 2020 (kilograms)
  • 6.5. Rest of the World (RoW)
    • 6.5.1. Rest of the World Albumin Market Revenue, 2012 - 2020 (USD Million)
    • 6.5.2. Rest of the World Albumin Market Volume, 2012 - 2020 (kilograms)

Chapter 7 - Recommendations

  • 7.1. Marketing Strategies for Success
  • 7.2. Barriers to be Considered

Chapter 8 - Company Profiles

  • 8.1. CSL Behring LLC
    • 8.1.1. Company Overview
    • 8.1.2. Financial Overview
    • 8.1.3. Product Portfolio
    • 8.1.4. Business Strategies
    • 8.1.5. Recent Developments
  • 8.2. HiMedia Laboratories
    • 8.2.1. Company Overview
    • 8.2.2. Financial Overview
    • 8.2.3. Product Portfolio
    • 8.2.4. Business Strategies
    • 8.2.5. Recent Developments
  • 8.3. InVitria (Ventria Bioscience)
    • 8.3.1. Company Overview
    • 8.3.2. Financial Overview
    • 8.3.3. Product Portfolio
    • 8.3.4. Business Strategies
    • 8.3.5. Recent Developments
  • 8.4. MedxBio Pte. Ltd.
    • 8.4.1. Company Overview
    • 8.4.2. Financial Overview
    • 8.4.3. Product Portfolio
    • 8.4.4. Business Strategies
  • 8.5. Mitsubishi Tanabe Pharma
    • 8.5.1. Company Overview
    • 8.5.2. Financial Overview
    • 8.5.3. Product Portfolio
    • 8.5.4. Business Strategies
    • 8.5.5. Recent Developments
  • 8.6. Novozymes A/S
    • 8.6.1. Company Overview
    • 8.6.2. Financial Overview
    • 8.6.3. Product Portfolio
    • 8.6.4. Business Strategies
    • 8.6.5. Recent Developments
  • 8.7. Octapharma AG
    • 8.7.1. Company Overview
    • 8.7.2. Financial Overview
    • 8.7.3. Product Portfolio
    • 8.7.4. Business Strategies
    • 8.7.5. Recent Developments
  • 8.8. RayBiotech, Inc.
    • 8.8.1. Company Overview:
    • 8.8.2. Financial Overview
    • 8.8.3. Product Portfolio
    • 8.8.4. Business Strategies
    • 8.8.5. Recent Developments
  • 8.9. Sigma-Aldrich Corporation
    • 8.9.1. Company Overview
    • 8.9.2. Financial Overview
    • 8.9.3. Product Portfolio
    • 8.9.4. Business Strategies
    • 8.9.5. Recent Developments
  • 8.10. Thermo Fisher Scientific
    • 8.10.1. Company Overview
    • 8.10.2. Financial Overview
    • 8.10.3. Product Portfolio
    • 8.10.4. Business Strategies
    • 8.10.5. Recent Developments

List of Figures

  • FIG. 1: Market Segmentation: Global Albumin Market
  • FIG. 2: Comparative Analysis: Global Albumin Market Revenue, by Geography, 2013 &2020 (Value %)
  • FIG. 3: Global Albumin Market Volume, by Geography, 2012 - 2020 (Kilograms)
  • FIG. 4: Porter's Five Forces Analysis: Global Albumin Market
  • FIG. 5: Market Attractiveness Analysis: Global Albumin Market, by Geography, 2013
  • FIG. 6: Comparative Analysis: Global Albumin Market Revenue, by Type, 2013 &2020 (Value %)
  • FIG. 7: Global HSA Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 8: Global BSA Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 9: Global rAlbumin Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 10: Comparative Analysis: Global Albumin Market Revenue, by Application, 2013 &2020 (Value %)
  • FIG. 11: Global Drug Formulation and Drug Delivery Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 12: Global Drug Formulation and Drug Delivery Market Volume, 2012 - 2020 (kilograms)
  • FIG. 13: Global Vaccines Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 14: Global Vaccines Market Volume, 2012 - 2020 (kilograms)
  • FIG. 15: Global Component of Media Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 16: Global Component of Media Market Volume, 2012 - 2020 (kilograms)
  • FIG. 17: North America Albumin Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 18: North America Albumin Market Volume, 2012 - 2020 (kilograms)
  • FIG. 19: Europe Albumin Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 20: Europe Albumin Market Volume, 2012 - 2020 (kilograms)
  • FIG. 21: Asia Pacific Albumin Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 22: Asia Pacific Albumin Market Volume, 2012 - 2020 (kilograms)
  • FIG. 23: Rest of the World Albumin Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 24: Rest of the World Albumin Market Volume, 2012 - 2020 (kilograms)
  • FIG. 25: CSL Behring, Inc.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 26: Mitsubishi Tanabe Pharma: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 27: Novozymes: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 28: Octapharma AG: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 29: Sigma-Aldrich Corporation: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 30: Thermo Fisher Scientific: Annual Revenue, 2011 - 2013 (USD Million)

List of Tables

  • TABLE 1: List of Abbreviations
  • TABLE 2: Market Snapshot: Global Albumin Market (2013 & 2020)
  • TABLE 3: Event Impact Analysis: Global Albumin Market
  • TABLE 4: Ongoing Clinical Trials with Albumin as an Excipient
  • TABLE 5: Global Albumin Market Revenue, by Type, 2012 - 2020 (USD Million)
  • TABLE 6: Price Range for Each Albumin Type (USD/ kg)
  • TABLE 7: Global Albumin Market Revenue, by Application, 2012 - 2020 (USD Million)
  • TABLE 8: Global Albumin Market Revenue, by Geography, 2012 - 2020 (USD Million)
  • TABLE 9: Global Albumin Market Volume, by Geography, 2012 - 2020 (kilograms)
Back to Top